It has been shown that combined liver-kidney normothermic machine perfusion (NMP) is able to better maintain the circuit's biochemical milieu. Nevertheless, whether the combined perfusion is superior to liver perfusion alone in protecting livers from donation after circulatory death (DCD) is unclear. We aimed to test the hypothesis and explored the mechanisms. Livers from 15 DCD pig donors were subjected to either static cold storage (group A), liver-alone NMP (group B), or combined liver-kidney NMP (group C). Livers were preserved for 6 hours and reperfused ex vivo for 2 hours to simulate transplantation or were transplanted in situ. During perfusion, group C showed an improved acid-base and biochemical environment in the circuit over group B. After reperfusion, the architecture of the liver grafts was best preserved in group C, followed by group B, then group A, as shown by the histology and terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate nick-end labeling staining of both hepatocytes and biliary epithelium. Ki-67 staining showed substantial hepatocyte proliferation and biliary epithelial regeneration after perfusion in group B and group C. Group C produced more bile in the reperfusion phase than those in group A and group B, with more physiological bile composition and less severe biliary epithelium injury. Von Willebrand factor-positive endothelial cells and E-selectin expression decreased in both group B and group C. Combined liver-kidney NMP not only produced more adenosine triphosphate, protected the nitric oxide signaling pathway, but also diminished oxidative stress (high mobility group box-1 protein and 8-hydroxy-2-deoxy guanosine levels) and inflammatory cytokine (IL6 and IL8) release when compared with liver-alone NMP and CS. In addition, the 7-day survival rate of liver transplant recipients was higher in group C than that in groups A and B. In conclusion, combined liver-kidney NMP can better protect DCD livers from warm ischemia and reperfusion injury probably by maintaining the stability of the internal environment and by abolishing oxidative stress injury.
now, resulting in a higher risk of graft loss due to primary nonfunction and biliary complications compared with standard criteria organs in liver transplantation. (3) (4) (5) Therefore, liver utilization remains suboptimal, with organ discard rates ranging from 20% to 40% in the United States. (3) Normothermic machine perfusion (NMP) is a promising preservation method, keeping the liver grafts at a physiological temperature and providing adequate oxygen supply to maintain aerobic metabolism during preservation. Several studies have displayed its superiority over CS in the preservation of DCD livers. (6) (7) (8) (9) However, Reiling et al. (10) have reported that the acid-base disturbance, increased urea and glucose levels, might cause unexpected injury to hepatocytes and biliary tract during perfusion. For another, it has been shown that the addition of the kidney to the liver NMP system is able to better maintain the circuit's biochemical milieu. (11) We hypothesize that combined liver-kidney perfusion is superior to liver perfusion alone in protecting DCD livers from warm ischemia injury. This study aims to test the hypothesis and explore the underlying mechanisms.
Materials and Methods

ANIMALS
A total of 30 healthy male Ba-Ma miniature swine (25-35 kg) , aged older than 13 months, were purchased from Guangzhou Feed Research Institute (Guangzhou, China). Animals were housed and fed in accordance with the relevant national and international guidelines. (12, 13) All experimental procedures and protocols were approved by the Committee on the Ethics of Animal Experiments of The First Affiliated Hospital of Sun Yat-Sen University. The animals were given access to food and water ad libitum and were restricted from food but not water 12 hours before the operation. All operations were performed under general anesthesia, and all efforts were made to minimize suffering.
ORGAN RETRIEVAL
After anesthesia, pigs were laid on the operating table in a supine position. The internal jugular veins and carotid arteries were dissected and catheterized for preparation. Two DCD models were used in this study. In the transplantation simulation setting, cardiac arrest was induced with 40 mEq of intravenous potassium chloride, the livers and kidneys were exposed to 30 minutes in situ, no-touch warm ischemia before they were flushed in situ through the abdominal aorta (AA) and portal vein (PV) with 2 L of University of Wisconsin (UW) solution at 48C. In the orthotopic liver transplantation (OLT) setting, cardiac arrest was induced by exsanguination and respirator withdrawal. After 30 minutes of in situ functional warm ischemia time, the liver and kidneys were flushed in situ through the AA and PV with 2 L of UW solution at 48C. The liver and kidney grafts were harvested using a standard protocol. (14) ORGAN PRESERVATION After organ procurement, the livers were randomly assigned to be preserved in the CS group (group A, n 5 5), the liver-alone NMP group (group B, n 5 5), eosin; HA, hepatic artery; HMGB1, high mobility group box-1 protein; IL, interleukin; IRI, ischemia/reperfusion injury; ITBL, ischemic-type biliary lesion; KI, Ki-67 labeling index; LFT, liver function test; NMP, normothermic machine perfusion; NO, nitric oxide; OLT, orthotopic liver transplantation; PBG, peribiliary gland; PV, portal vein; RA, renal artery; ROS, reactive oxygen species; TBIL, total bilirubin; TNF-a, tumor necrosis factor a; TUNEL, terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate nick-end labeling; UW, University of Wisconsin; vWF, von Willebrand factor.
or the combined liver-kidney NMP group (group C, combined the liver and a kidney, n 5 5) for 6 hours. The NMP system ( Fig. 1 ) was comprised of a peristaltic pump (PD5206, Heidolph, Germany), a membrane oxygenator (70058174, Maquet, Germany), a softshell reservoir, a gate clamp, a pressure sensor (DPT-248, SCW MEDICATH, Ltd., China), a multilead physiological recorder (N12128, Australia), a heat exchange water tank (HICO-VARIOTHERM 550, Germany), and the cannula system. The perfusate is composed of 800 mL of blood, 800 mL of normal saline, 600 mg of reduced glutathione sodium injection, 1.5 g of cefuroxime sodium injection, and 10 mg of alprostadil injection. The reservoir was placed in the heat exchange water tank to maintain a perfusate temperature at 398C. (15) Perfusion was started once the organs were connected and then maintained for 6 hours. In all experiments, an oxygenator administered a constant rate of oxygen at 200 mL/minute, maintaining the oxygen partial pressure at 250-500 mm Hg and carbon dioxide partial pressure at 30-50 mm Hg, respectively. The oxygenated perfusate recirculated via the hepatic artery (HA) and PV into the livers (dual perfusion) and via the renal artery (RA) into the kidneys. Gate clamps were installed in the HA, PV, and RA perfusion pathways to regulate the perfusion pressure via adjustments of the inner caliber of the pathway. Perfusion was maintained within physiological hemodynamic values for arterial and venous pressures by altering the pump speed and changing the in-flow resistances. The PV flow (310-590 mL/minute) was maintained at a pressure of 8-10 mm Hg, and the HA flow (110-240 mL/minute) was maintained at a perfusion pressure of 80-100 mm Hg. The RA flow (90-100 mL/minute) was maintained at a perfusion pressure of 40-60 mm Hg. In order to reproduce normal physiological conditions as closely as possible, during the perfusion, heparin (12,500 U in 50 mL normal saline, 4 mL/hour), insulin (100 U of insulin in 47.5 mL of normal saline, 3-5 mL/hour), 5% glucose (10 mL/hour), and compound amino acid (5% compound amino acid, 10 mL/hour: 1.8 g of alanine, 1.23 g of arginine, 0.38 g of aspartate, 0.05 g of cystine, 0.63 g of glutamic acid, 0.88 g of glycine, 0.75 g of histidine, 0.63 g of isoleucine, 0.85 g of leucine, 1.38 g of lysine acetate, 0.63 g of methionine, 0.88 g of phenylalanine, 0.73 g of proline, 0.48 g of serine, 0.63 g of threonine, 0.21 g of tryptophan, 0.05 g of tyrosine, and 0.8 g of valine) were continuously infused through microinjection pumps into the circuit. The extra fluid loss because of production of hemofiltrated urine in group C was replaced according to the produced urine volume and hematocrit levels during the experiment.
REPERFUSION TO SIMULATE TRANSPLANTATION
In the first 15 cases, to assess organ viability and ischemia/reperfusion injury (IRI) after preservation, after 6-hour preservation, all the livers in 3 groups were placed FIG. 1. Scheme of the perfusion system. The perfusion system was composed of an organ chamber, a roller pump, an oxygenator, and a heat exchanger. All of these compartments were connected by tubing. Infusion pumps were connected to ports along the tubing to infuse medications and supplements. Sampling ports are present in both the afferent and efferent arms of the circuits perfusing the liver.
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on the perfusion machine and reperfused with 2 L whole blood at 398C for 2 hours to replicate clinical transplantation.
OLT PROCEDURE AND POSTOPERATIVE MANAGEMENT
In the second 15 cases, after 6-hour preservation, the liver grafts were flushed with warm normal saline and transplanted using a bicaval procedure. The donor common HA was end-to-end anastomosed to the recipient common HA. The anhepatic phase was 22-25 minutes. The administration of intravenous fluids was standard (500 mL of Ringer's solution during hepatectomy and after reperfusion, 500 mL of colloid during the anhepatic phase, and 500 mL of 5% glucose and sodium chloride after transplantation); 500 mL of Ringer's solution and 500 mL of glucose were used daily after transplantation; 500 mg of methylprednisolone was used intraoperatively, and 250 mg of methylprednisolone was used daily after transplantation. The recipient was followed intensively for up to 7 days.
HISTOLOGICAL ANALYSIS
All liver samples were fixed in 10% buffered formalin, embedded in paraffin, and sectioned (5 mm) and stained with hematoxylin-eosin (H & E) for histological analyses. The IRI of the livers was blindly graded by 2 transplant pathologists. The injury to the liver parenchyma/bile duct was evaluated via light microscopy with a semiquantitative scoring system as previously reported. (16, 17) IMMUNOHISTOCHEMISTRY AND APOPTOSIS ASSAY Samples slides were prepared for immunohistochemical detection of von Willebrand factor (vWF) and Ki-67 according to a previous report. (18) Apoptosis was detected by terminal deoxynucleotidyl transferasemediated deoxyuridine triphosphate nick-end labeling (TUNEL) according to the instructions. The apoptotic index (AI) and the Ki-67 labeling index (KI) were calculated as the percentage of positive nuclei divided by the total number of cells examined. At least 1000 cells per specimen were examined in 5 randomly selected fields by light microscopy (3400).
BIOCHEMICAL ANALYSIS
The supernatant of the perfusion fluid and blood of transplant recipients was collected for detection of aspartate aminotransferase (AST), alanine aminotransferase (ALT), and lactate dehydrogenase, using standard biochemical methods. The pH value, glucose, and urea levels were detected hourly by blood gas analysis.
BILE PRODUCTION AND BILIARY INJURY ASSESSMENT
Bile production was measured every hour from the biliary drainage tube. Bile samples were collected under mineral oil and analyzed. The pH value, bicarbonate, and gamma-glutamyl transferase (GGT) in bile were measured as biomarkers of biliary epithelial cell function and injury, (18) and total bilirubin (TBIL) levels in bile were measured as a biomarker of hepatocellular secretory function. (19) 
ADENOSINE TRIPHOSPHATE DETECTION
The adenosine triphosphate (ATP) level in liver tissue was measured by the luciferin-luciferase method with the ATP Bioluminescence Assay Kit (K791, Biovision, Milpitas, CA) according to manufacturer's instructions and normalized to protein content.
INFLAMMATORY FACTORS AND WESTERN BLOT
Interleukin (IL) 6, IL8, tumor necrosis factor a (TNF-a), 8-hydroxy-2-deoxy guanosine (8-OHdG) and high mobility group box-1 protein (HMGB1) in tissues, and the Western blot of E-selectin, adenosine monophosphate-activated protein kinase (AMPK), endothelial nitric oxide synthase (eNOS) were conducted as described previously (3, 20) with some modifications.
STATISTICAL ANALYSIS
The data analysis was performed using SPSS, version 20.0 software (SPSS, Chicago, IL). Mean and standard deviation were used for describing parametric variables. Median and range were used for describing nonparametric variables. Normality assumptions were demonstrated with histograms and the Kolmogorov/ Smirnov test. Differences over the period of the study for the other variables analyzed were assessed with the analysis of the variance test for repeated measures. Two group comparisons of continuous measures were conducted using the 2-sample t test or Wilcoxon rank sum test. Survival was analyzed according to the Kaplan-Meier method; differences between groups were evaluated using the log-rank test. P < 0.05 was considered statistically significant.
Results
COMBINED LIVER-KIDNEY PERFUSION IMPROVES THE ACID-BASE AND BIOCHEMICAL ENVIRONMENT IN THE CIRCUIT
We observed urine production during the perfusion in group C. The urine production went up initially and peaked at the fourth hour and thereafter maintained a stable state until the sixth hour of perfusion ( Fig. 2A) . The urine routine test showed that the pH value of urine was maintained at 6.0 during perfusion, and the urine specific gravity was between 1.011 and 1.018, with glucose ranging from (1) to (111). H & E staining of kidney biopsies after reperfusion showed normal histologic architecture in group C (Fig. 2B) . These data suggested a functioning kidney graft during NMP.
We found that the pH values at the end of both perfusion and reperfusion in group B tended to be more alkalotic than those in group C (perfusion, 7.58 6 0.15 versus 7.33 6 0.16; P 5 0.03; reperfusion, 7.49 6 0.13 versus 7.37 6 0.17; P 5 0.046; Fig. 2C ). The bicarbonate levels at the end of both perfusion and reperfusion in group B were significantly higher than those in group C (17.10 6 0.16 versus 8.48 6 3.92 mmol/L; P 5 0.03; 16.83 6 7.42 versus 9.21 6 2.08 mmol/L; P 5 0.02; Fig. 2D ).
The glucose levels rose from almost euglycemia to hyperglycemia during perfusion in group B. However, the glucose levels in group C showed an initial and significant rise, and then decreased to be almost euglycemia during the perfusion (Fig. 2E) . The urea levels progressively increased during perfusion in group B. Nevertheless, the urea levels in group C were low during perfusion. At the end of perfusion, the urea levels were significantly lower in group C than in group B (4.13 6 1.83 versus 11.70 6 5.29 mg/dL; P 5 0.04; Fig. 2F ).
COMBINED LIVER-KIDNEY NMP FURTHER ALLEVIATES HEPATOCYTE INJURY
After reperfusion, light microscopy of biopsies from the liver parenchyma showed the largest areas of necrosis in group A and minimal necrosis in group B, and almost normal histologic architecture in group C (Fig. 3A) . The histological score was lower in group C (2.60 6 1.14) than those in group A (12.00 6 2.34) and group B (5.60 6 1.82; both P values < 0.05; Fig.  3B ). Similarly, there were much less apoptosis cells in group C (AI, 8.00 6 2.30) than in group A (AI, 35.00 6 5.15; P < 0.001) and group B (AI, 20.00 6 4.15; P 5 0.01; Fig. 3C,D) . Notably, hepatocyte proliferation, as indicated by Ki-67 immunostaining, was very prominent (KI, 83.00 6 3.83) in the combined liverkidney NMP group, in comparisons with the liveralone NMP group (KI, 63.00 6 9.12; P 5 0.02) and CS group (KI, 31.00 6 6.23; P < 0.001; Fig. 3E,F) .
During the preservation phase, increased AST and ALT levels were documented in both group B and group C. The enzymes increased substantially in the first hour and reached a platform at the fourth hour. At the end of the reperfusion phase, the AST and ALT levels increased to 1271.00 6 136.00 U/L and 126.00 6 21.00 U/L in group A, which were higher than group B (AST, 869.00 6 171.00 U/L; ALT, 97.00 6 13.00 U/L; both P values < 0.001). The combined liver-kidney NMP further alleviated hepatocyte injury (AST, 481.00 6 212.00 U/L; ALT, 68.00 6 10.00 U/L) when compared with liver-alone NMP (both P values < 0.001; Fig. 3G,H) . Similarly, at the end of the reperfusion phase, the TBIL levels increased to 103.28 6 17.44 mmol/L in group A, which were higher than in group B (49.93 6 21.03 mmol/L; P < 0.001). The TBIL levels were lower (20.19 6 4.96 mmol/L) in the combined liver-kidney NMP group when compared with the liver-alone NMP group (P 5 0.02; Fig. 3I ).
COMBINED LIVER-KIDNEY NMP FURTHER ALLEVIATES BILIARY EPITHELIAL INJURY
More severe injury of bile ducts was found after CS with prominent epithelial cell loss and mural stroma necrosis (histological score, 21.00 6 3.67), whereas there was only mild injury in group B (histological score, 12.20 6 2.59). The biliary epithelial cell layer was almost complete, and no sign of mural stroma
necrosis was documented in the combined liver-kidney NMP group (histological score, 5.40 6 3.65; Fig.  4A,B) . There was less apoptosis of biliary epithelium in group C (AI, 7.00 6 2.07) when compared with group B (AI, 16.00 6 3.80) and group A (AI, 27.00 6 3.54; P 5 0.01 and P < 0.001; Fig. 4C,D) . Interestingly, obvious cholangiocyte proliferation was found in group C (Fig. 4E,F) . The liver grafts in group A had no bile production during the preservation phase and very limited bile production (2 6 1 mL) in the 2-hour reperfusion phase. In contrast, the liver grafts in group B produced 22 6 2 mL of bile during the preservation phase and 9 6 1 mL bile during the reperfusion phase. The livers in group C produced more bile during preservation phase (27 6 4 mL) and reperfusion phase (14 6 2 mL) than those in group B (both P values < 0.05; Fig. 4G ). As for bile composition during the 6-hour perfusion, the bicarbonate and TBIL levels increased constantly and yet GGT decreased constantly in both group B and group C. After reperfusion, the bicarbonate and TBIL levels were the highest in group C (22.80 6 1.92 mmol/L and 574.74 6 59.05 
COMBINED LIVER-KIDNEY NMP INCREASES ATP PRODUCTION DURING THE PRESERVATION PERIOD
Because of a reduction in aerobic metabolism with static CS, the existence of anaerobic metabolism causes lactic acid production and subsequent injury. In this study, during the preservation phase, the tissue ATP content increased significantly from 59. 10 23 ) pmol/mg protein, which was significantly lower than in both group B and group C (both P values < 0.001; Fig. 5A ). Additionally, liveralone NMP obviously decreased the lactic acid levels when compared with static CS (3.34 6 0.73 versus 11.26 6 2.26 mmol/L; P < 0.001), whereas combined liver-kidney NMP further decreased the lactic acid level (1.47 6 1.02 mmol/L) when compared with liver-alone NMP (P 5 0.04; Fig. 5B ). 
COMBINED LIVER-KIDNEY NMP ABOLISHES OXIDATIVE STRESS AND INFLAMMATION DURING REPERFUSION
More vWF-positive endothelial cells were documented in the livers under CS, followed by liveralone NMP and combined liver-kidney NMP. Eselectin expression in the combined liver-kidney NMP group also decreased over time during the perfusion (Fig. 5C,D) . Moreover, flow-related shear stress is one of the most potent stimuli for nitric oxide (NO) release. Expression of both eNOS and AMPK was found to increase after perfusion, suggesting that combined perfusion might increase eNOS via upregulation of AMPK (Fig. 5E ). HMGB1 reflects nuclear subcellular injury, and 8-OHdG is a product of oxidative damage of DNA by reactive oxygen. Combined liver-kidney NMP decreased HMGB1 and 8-OHdG levels when compared with liver-alone NMP and CS. Kupffer cell activation was minimized with a decreased release of TNF-a in NMP groups as compared with CS group. Furthermore, we analyzed several inflammatory cytokines and found a significant increase of IL6 and IL8 over time compared with baseline levels during NMP. At the end of reperfusion, the IL6 (55.16 6 21.62 pg/mL) and IL8 (6.82 6 2.58 pg/mL) levels were lower in the combined liver-kidney NMP group when compared with the liver-alone NMP group (IL6, 129.99 6 10.10 pg/ mL; IL8, 38.10 6 2.53 pg/mL) and CS group (IL6, 262.33 6 40.85 pg/mL; IL8, 81.51 6 13.42 pg/mL; all P values < 0.05; Fig. 5F-5J ).
COMBINED LIVER-KIDNEY NMP IMPROVES RECIPIENT SURVIVAL OF LIVER TRANSPLANTATION
Seven-day survival was 0% and 60% in the CS group and the liver-alone NMP group. Combined liverkidney NMP improved recipient survival (80%, 1 death due to a surgical issue) when compared with the liveralone NMP group (P 5 0.02; Fig. 6A ). The liver function tests (LFTs) were lower in the combined liverkidney NMP group, in comparison to the liver-alone NMP group (ALT, 57.10 6 5.12 versus 87.60 6 8.57 U/L; P 5 0.02; AST, 356.10 6 38.59 versus 787.6 6 175.3 U/L; P 5 0.04) on day 1 after transplantation. Besides, the lactate levels on day 1 after transplantation were lower in group C than those in group B (0.45 6 0.09 versus 0.98 6 0.08 mmol/L; P 5 0.008; Fig. 6B ). The histological studies of biopsies obtained at 30 minutes after allograft revascularization showed minimal IRI in the combined liver-kidney NMP group (Fig. 6C) . The histological scores were lower in group C (2.80 6 0.49) than those in group A (12.80 6 1.39; P < 0.001) and group B (5.80 6 0.97; P 5 0.02).
Discussion
Liver transplant volume has been relatively stagnant for the past decade, whereas indications for the procedure continue to expand. However, the volume of available livers does not expand in parallel, which results in an unacceptable number of deaths on the waiting list. (21) It is therefore urgent to search for an effective method that we can improve the viability and usability of currently available but discarded organs. Machine perfusion is receiving increasing attention as an attractive alternative for static CS of liver grafts before transplantation. Several studies have shown that the use of NMP is associated with decreased hepatocellular injury and better allograft function. (6) (7) (8) (9) However, the lack of homeostatic organs generates biochemical changes during perfusions, such as steadily rising urea and glucose levels in the circuit, which may be caused by the continuation of urea cycle activity in the hepatocytes and high insulin-resistant glycogenolytic activity. (10) These changes contribute substantially to a steady rise in osmolality, to which human tissues are sensitive. Additional to an osmotic effect, it has been shown that a high concentration of urea (100 mmol/L) negatively affects hepatic metabolism via proteolysis inhibition. (22) For this reason, Banan et al. (23) incorporated a dialyzer to clear the urea and glucose in the circuit, but it would not be feasible in a portable system. Also, the costs of adding a dialyzer to the system will be $20,000-$30,000. (24) The kidney is a homeostatic organ, which can remove the excess metabolite. The Leicester group has shown that the addition of a kidney to the liver circuit is able to provide more stable physiological milieu without increased cytokine response. (25) Consistent with this finding, the pH value and bicarbonate level were found to be lower and more steady in the combined liver-kidney circuit than in the liver-alone circuit in this study. Moreover, the glucose level under combined perfusion showed a decline during the perfusion, with lower glucose and urea levels than liver-alone perfusion. However, whether a more physiological milieu is able to translate into a better preserved organ is still unknown.
The researchers usually use 2 methods to test the graft viability after preservation in animal studies, (15, 18, 24, (26) (27) (28) (29) (30) (31) (32) including ex vivo graft reperfusion under NMP to simulate transplantation, (15, 18, 24, 26, 27, (29) (30) (31) or in vivo OLT. (28, 32) In this study, we tested the protective benefits of combined liver-kidney NMP using both ex vivo and in vivo methods. Notably, the methods used to induce cardiac death varied from different studies using porcine DCD models. The use of potassium chloride is the most frequently used method in the related studies due to its simplicity, (15, 18, 24, (26) (27) (28) although this model is not able to perfectly mimic the clinical DCD settings. Therefore, we opted to induce cardiac death by the use of potassium chloride in the ex vivo testing model, but induce cardiac death by exsanguination and respirator withdrawal in the in vivo testing model.
In this study, we documented a better preservation of both hepatocytes and biliary epithelium by combined liver-kidney NMP when compared with liveralone NMP and CS, as shown by H & E and TUNEL staining. Besides, the LFTs during preservation, after reperfusion or transplantation showed clearly the superiority of combined NMP over liver-alone NMP. Importantly, DCD liver grafts produced more "physiological" bile, and further decreased the lactic acid level of liver grafts under the combined NMP mode when compared with the liver-alone NMP mode. Moreover, combined liver-kidney NMP further improved posttransplant recipient survival. Collectively, for the first time, we showed that combined liver-kidney NMP is superior to liver-alone NMP in repairing hepatocyte and biliary injury.
Ischemic-type biliary lesion (ITBL) is a common complication in DCD liver transplantation, which is the most frequent reason for retransplantation. (33) One potential advantage of NMP over CS is that perfusion might better preserve the peribiliary plexus and decrease the incidence of ITBL. (26) Interestingly, op den Dries et al. (34) postulate that biliary epithelium regeneration after a major ischemic event such as during DCD can be possible only if the integrity of the microvascular plexus serving the bile duct and peribiliary glands (PBGs) is maintained. In the current study, the Ki-67 staining showed more active cholangiocyte proliferation in both superficial and deep PBGs in group C than in group B. In contrast, Ki-67 staining was virtually absent in the bile duct preserved under CS. Convincing evidence indicates that PBGs host multipotent stem cells that are able to differentiate into cholangiocytes, and they contribute to the renewal/ repair of biliary epithelium under both physiological and pathological conditions. (35, 36) Combined NMP might simulate the differentiation of stem cells into cholangiocytes, which might be of benefit for protecting recipients from ITBL in clinical practice.
The absence of oxygen in machine perfusion fails to prevent reperfusion injury; instead, it provokes mitochondrial and nuclear injury with the release of HMGB1 and 8-OHdG protein. HMGB1 release from the nucleus of necrotic cells involves toll-like receptor-4 activation of Kupffer cells, as an initiator of the innate immune response. (31, 37) Interestingly, liver allografts after CS exhibited the highest HMGB1 level, and those after combined perfusion showed the lowest level. As HMGB1 release is known to be induced by intracellular reactive oxygen species (ROS), (31, 38, 39) these results suggest a link between mitochondrial oxidative stress and HMGB1 release during early ischemia/reperfusion. It also supports the view that NMP may be a strategy to decrease reperfusion injury, and the combined liver-kidney perfusion may help to further diminish reperfusion injury in comparison to liver-alone perfusion.
Activated Kupffer cells in the hepatic IRI may also release multifarious cytokines and chemokines which trigger platelets. Platelet aggregation decreases sinusoidal flow and activates neutrophils, resulting in further aggravation of intravasal ROS production. (31) vWF is a factor reflecting the platelet aggregation and the activation of endothelial cells. (16) Our results showed vWF staining was prominent in group A and almost absent in group C, with intermediate staining in group B. Eselectin expression in the combined liver-kidney NMP group also showed a decrease over time. These data may display more activated Kupffer cells in liver grafts after CS and less activated Kupffer cells and endothelial cells after NMP. Accordingly, the proinflammatory cytokines such as TNF-a, IL6, and IL8 were also found the highest in group A. Furthermore, endothelial cells are constantly exposed to flow. Flow-related shear stress is one of the most potent stimuli for NO release, which is a potent vasodilator. (20) We demonstrated that combined liver-kidney NMP might protect the NO signaling pathway by up-regulation of eNOS through an AMPK-a-dependent mechanism.
The warm ischemia which characterizes the process of DCD donation could cause a dramatic drop in intracellular ATP long before liver flushing and cooling. The liver thereafter enters a cold ischemia phase with a profound energy debt. The lack of ATP, along with the direct inhibition caused by the low temperature, impairs the function of the Na/K pump, a key enzyme involved in the prevention of cell swelling and death. (18) Cell death is therefore further amplified after reperfusion. Recovered ATP content appears to be a good indicator of mitochondrial respiratory function and the reduction of oxidative stress. Moreover, a poor recovery of ATP is associated with worse LFTs. NMP is able to restore mitochondrial respiratory function and reverse energy deficits. (40) In this study, we found further augmentation of tissue ATP content after combined liver-kidney NMP when compared with liver-alone NMP, suggesting combined perfusion is able to better maintain mitochondrial respiratory function.
In conclusion, combined liver-kidney NMP displays a more active repairing capability by maintaining the stability of the internal environment in the circuit and decreasing inflammatory injury. We have designed a combined liver-kidney NMP device, which can perfuse 1 liver, or 1 or 2 kidneys, or 1 liver with 1 or 2 kidneys. In the future, this device might be used to enhance the protective effects when a liver and 1 or 2 kidneys are allocated to 1 organ transplant center, which is not a rare case in clinical practice.
